Skip to main content
Top
Published in: Abdominal Radiology 5/2019

01-05-2019 | Interventional Radiology | Interventional Radiology

Complication rates of percutaneous biliary drainage in the presence of ascites

Authors: Viren Patel, Shaun W. McLaughlin, Richard Shlansky-Goldberg, Terence Gade, Ryan Bonshock, Stephen Hunt, S. William Stavropoulos, Scott O. Trerotola, Michael C. Soulen, Gregory Nadolski

Published in: Abdominal Radiology | Issue 5/2019

Login to get access

Abstract

Background

Ascites is a relative contraindication to percutaneous biliary drainage (PBD), but patients with biliary obstruction presenting with ascites may still undergo PBD insertion. We hypothesized that ascites increases the major complication rate of PBD.

Materials

PBDs placed between January 2005 and August 2016 were identified (n = 491). Etiology and location of obstruction, the presence, and distribution of ascites based on abdominal imaging within 2 weeks of PBD, INR, WBCE, and peri-procedural complications were reviewed in the EMR.

Results

A total of 491 PBD were placed during the study period of which 26.2% had ascites (n = 129), and 73.7% did not have ascites (n = 362). Ascites was categorized as perihepatic in 41 patients (32%), diffuse in 82 patients (64%), and non-perihepatic in 6 patients (4%). Overall, a significantly higher rate of major complications occurred in patients with ascites (19%) compared to that in patients without ascites (7.7%, P = 0.0004). Diffuse ascites was associated with a significantly higher major complication rate (26%) when compared to perihepatic ascites (7.3%, P = 0.014). In ascites patients, no association between the etiology of biliary obstruction or laterality of the PBD and the rate of major complications was identified.

Conclusions

The major complication rate in patients with ascites not only exceeds SIR suggested threshold of 10% but is also significantly higher than that patients without ascites. The distribution of ascites had a significant effect on complication rate, with diffuse ascites being associated with increased major complication rates compared to those with perihepatic. These findings suggest careful consideration of patients for PBD with ascites, particularly diffuse ascites.
Literature
1.
go back to reference Covey, A.M. and K.T. Brown, Percutaneous transhepatic biliary drainage. Tech Vasc Interv Radiol, 2008. 11(1): p. 14-20.CrossRefPubMed Covey, A.M. and K.T. Brown, Percutaneous transhepatic biliary drainage. Tech Vasc Interv Radiol, 2008. 11(1): p. 14-20.CrossRefPubMed
2.
go back to reference Saad, W.E., et al., Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol, 2010. 21(6): p. 789-95.CrossRefPubMed Saad, W.E., et al., Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol, 2010. 21(6): p. 789-95.CrossRefPubMed
3.
go back to reference Winick, A.B., P.N. Waybill, and A.C. Venbrux, Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol, 2001. 4(3): p. 200-6.CrossRefPubMed Winick, A.B., P.N. Waybill, and A.C. Venbrux, Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol, 2001. 4(3): p. 200-6.CrossRefPubMed
4.
go back to reference Lucatelli, P., et al., Risk Factors for Immediate and Delayed-Onset Fever After Percutaneous Transhepatic Biliary Drainage. Cardiovasc Intervent Radiol, 2016. 39(5): p. 746-55.CrossRefPubMed Lucatelli, P., et al., Risk Factors for Immediate and Delayed-Onset Fever After Percutaneous Transhepatic Biliary Drainage. Cardiovasc Intervent Radiol, 2016. 39(5): p. 746-55.CrossRefPubMed
5.
go back to reference Lucatelli, P., et al., Risk Factors for Immediate and Delayed-Onset Fever After Percutaneous Transhepatic Biliary Drainage. Cardiovasc Intervent Radiol, 2016. 39(5): p. 746-55.CrossRefPubMed Lucatelli, P., et al., Risk Factors for Immediate and Delayed-Onset Fever After Percutaneous Transhepatic Biliary Drainage. Cardiovasc Intervent Radiol, 2016. 39(5): p. 746-55.CrossRefPubMed
6.
go back to reference Tapping, C.R., O.R. Byass, and J.E. Cast, Percutaneous transhepatic biliary drainage (PTBD) with or without stenting-complications, re-stent rate and a new risk stratification score. Eur Radiol, 2011. 21(9): p. 1948-55.CrossRefPubMed Tapping, C.R., O.R. Byass, and J.E. Cast, Percutaneous transhepatic biliary drainage (PTBD) with or without stenting-complications, re-stent rate and a new risk stratification score. Eur Radiol, 2011. 21(9): p. 1948-55.CrossRefPubMed
7.
go back to reference Duncan, C., et al., Outcomes of Percutaneous Cholecystostomy in the Presence of Ascites. J Vasc Interv Radiol, 2016. 27(4): p. 562-6 e1. Duncan, C., et al., Outcomes of Percutaneous Cholecystostomy in the Presence of Ascites. J Vasc Interv Radiol, 2016. 27(4): p. 562-6 e1.
9.
go back to reference Jarnagin, W.R., et al., Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg, 1998. 175(6): p. 453-60.CrossRefPubMed Jarnagin, W.R., et al., Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg, 1998. 175(6): p. 453-60.CrossRefPubMed
10.
go back to reference Funaki, B., et al., Percutaneous biliary drainage in patients with nondilated intrahepatic bile ducts. AJR Am J Roentgenol, 1999. 173(6): p. 1541-4.CrossRefPubMed Funaki, B., et al., Percutaneous biliary drainage in patients with nondilated intrahepatic bile ducts. AJR Am J Roentgenol, 1999. 173(6): p. 1541-4.CrossRefPubMed
11.
go back to reference Saluja, S.S., et al., Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol, 2008. 6(8): p. 944-950 e3. Saluja, S.S., et al., Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol, 2008. 6(8): p. 944-950 e3.
12.
go back to reference Carrasco, C.H., J. Zornoza, and W.J. Bechtel, Malignant biliary obstruction: complications of percutaneous biliary drainage. Radiology, 1984. 152(2): p. 343-6.CrossRefPubMed Carrasco, C.H., J. Zornoza, and W.J. Bechtel, Malignant biliary obstruction: complications of percutaneous biliary drainage. Radiology, 1984. 152(2): p. 343-6.CrossRefPubMed
13.
go back to reference Yee, A.C. and C.S. Ho, Complications of percutaneous biliary drainage: benign vs malignant diseases. AJR Am J Roentgenol, 1987. 148(6): p. 1207-9.CrossRefPubMed Yee, A.C. and C.S. Ho, Complications of percutaneous biliary drainage: benign vs malignant diseases. AJR Am J Roentgenol, 1987. 148(6): p. 1207-9.CrossRefPubMed
Metadata
Title
Complication rates of percutaneous biliary drainage in the presence of ascites
Authors
Viren Patel
Shaun W. McLaughlin
Richard Shlansky-Goldberg
Terence Gade
Ryan Bonshock
Stephen Hunt
S. William Stavropoulos
Scott O. Trerotola
Michael C. Soulen
Gregory Nadolski
Publication date
01-05-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01916-5

Other articles of this Issue 5/2019

Abdominal Radiology 5/2019 Go to the issue

Classics in Abdominal Radiology

Sentinel clot sign in hemoperitoneum

Classics in Abdominal Radiology

Playboy bunny sign

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.